Hemostasis and Anti-Inflammatory Abilities of AuNPs-Coated Chitosan Dressing for Burn Wounds.
Juin-Hong CherngCheng-An J LinCheng-Che LiuJue-Zong YehGang-Yi FanHsin-Da TsaiChun-Fang ChungSheng-Der HsuPublished in: Journal of personalized medicine (2022)
Burn injuries are a common hazard in the military, as fire is likely to be weaponized. Thus, it is important to find an effective substance to accelerate burn wound healing. This study used chitosan and gold nanoparticles (AuNPs) as wound dressings and investigated their effectiveness in femoral artery hemorrhage swine and rat burn models. Chitosan dressing has significant hemostatic properties compared with gauze. Histological results showed that burn wounds treated with chitosan or AuNP-coated chitosan dressings exhibited more cells and a continuous structure of the epidermis and dermis than those of the control and untreated lesion groups. Furthermore, both chitosan dressings have been shown to positively regulate the expression of genes- and cytokines/chemokines-related to the wound healing process; AuNP-coated chitosan significantly lessened severe sepsis and inflammation, balanced the activities of pro-fibrotic and anti-fibrotic ligands for tissue homeostasis, regulated angiogenesis, and inhibited apoptosis activity, thereby being beneficial for the burn microenvironment. Hence, chitosan alone or in combination with AuNPs represents a prospective therapeutic substance as a burn dressing which might be helpful for burn wound care. This study provides a novel hemostasis dressing for modern warfare that is simple to use by most medical and paramedical personnel handling for burn treatment.
Keyphrases
- wound healing
- gold nanoparticles
- oxidative stress
- healthcare
- anti inflammatory
- randomized controlled trial
- induced apoptosis
- intensive care unit
- systematic review
- stem cells
- drug delivery
- poor prognosis
- palliative care
- systemic sclerosis
- transcription factor
- genome wide
- dna methylation
- endothelial cells
- drug induced
- health insurance
- affordable care act
- combination therapy